Multiomics represents the subsets of omics – genomics, transcriptomics, proteomics, metabolomics, and phenomics. With a complete clinical picture via multiomic data, the process and precision of treating rare diseases is being redefined. We are able to gain multilayer insights to provide the most accurate diagnosis, develop better disease models, and thus deliver more precise medicine.
Learn more about MOx today and gain access to the multiomic solution that enables you to establish diagnostic decisions, better prognosis, and therapeutic approaches — laying the roadmap to personalized treatment options.
Below you can find CENTOGENE’s most recent study published in Nature, “The Multiomic Approach to Diagnosing Patients and Accelerating Treatments”, which looks at our first 3,720 patients.